Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide
- PMID: 2505013
- DOI: 10.1016/0882-4010(89)90087-9
Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide
Abstract
The protective properties of antibodies induced by immunization of mice with a conjugate of tetanus toxoid and the N-propionyl derivative of group B meningococcal polysaccharide (N-Pr-GBMP-TT) have been investigated. Mice immunized with the conjugate produced antibodies which were bactericidal for Neisseria meningitidis strains B:2b:P1.Ham and B:15:P1.16. Passive protection studies indicated that the conjugate serum completely eliminated or reduced considerably levels of bacteremia by the same strains in mice. There was no bactericidal activity or passive protection against a strain of N. meningitidis C:2b:P1.2. Following absorption of the conjugate serum with GBMP the non-absorbed antibody, directed to N-Pr-GBMP, was bactericidal and protected mice against bacteremia with group B meningococci. Thus N-Pr-GBMP antibodies which do not bind to the GBMP are protective in vitro and in vivo.
Similar articles
-
N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.J Exp Med. 1997 Jun 2;185(11):1929-38. doi: 10.1084/jem.185.11.1929. J Exp Med. 1997. PMID: 9166422 Free PMC article.
-
N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.J Exp Med. 1987 Apr 1;165(4):1207-11. doi: 10.1084/jem.165.4.1207. J Exp Med. 1987. PMID: 2435835 Free PMC article.
-
Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.J Immunol. 1986 Sep 1;137(5):1708-13. J Immunol. 1986. PMID: 3091688
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
-
[The capsular polysaccharide of serogroup-B meningococci: its immunobiological properties].Zh Mikrobiol Epidemiol Immunobiol. 1999 Sep-Oct;(5):52-6. Zh Mikrobiol Epidemiol Immunobiol. 1999. PMID: 10852023 Review. Russian. No abstract available.
Cited by
-
Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein.Infect Immun. 1999 Sep;67(9):4955-9. doi: 10.1128/IAI.67.9.4955-4959.1999. Infect Immun. 1999. PMID: 10456958 Free PMC article.
-
Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.Infect Immun. 2001 Nov;69(11):7130-9. doi: 10.1128/IAI.69.11.7130-7139.2001. Infect Immun. 2001. PMID: 11598089 Free PMC article.
-
Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.J Immunol. 2009 May 15;182(10):6610-7. doi: 10.4049/jimmunol.0803677. J Immunol. 2009. PMID: 19414816 Free PMC article.
-
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci.J Exp Med. 2006 Jan 23;203(1):111-8. doi: 10.1084/jem.20051540. Epub 2006 Jan 3. J Exp Med. 2006. PMID: 16390937 Free PMC article.
-
From empiricism to rational design: a personal perspective of the evolution of vaccine development.Nat Rev Immunol. 2014 Jul;14(7):505-14. doi: 10.1038/nri3694. Epub 2014 Jun 13. Nat Rev Immunol. 2014. PMID: 24925139 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials